Pep talk - November 2026

Elaine O'Brien has joined Qkine as Chief Executive Officer
We’re delighted to announce that Elaine O’Brien has joined Qkine as Chief Executive Officer. As Qkine enters its next phase of growth, Elaine brings extensive experience in scaling global life sciences businesses. Her previous roles at Horizon Discovery and Abcam spanned research reagents, commercial strategy and eCommerce. Most recently, she held an executive leadership position at venture-backed Camena Bioscience.
At Qkine, Elaine will focus on bringing together our R&D, operational and commercial capabilities to drive growth and expand our global customer base. Together, we aim to accelerate the adoption of our bioactive, high-purity growth factors across stem cell biology, organoid research and regenerative medicine.
We’re thrilled to welcome Elaine to the team and look forward to the exciting opportunities ahead as we begin this next chapter for Qkine.

WORD+2027 #FluorescenceFriday Competition
- Up to 20 Advanced Cell Model images will be chosen for display in the WORD+2027 Art Gallery.
- Each of the 20 finalists receives a complimentary WORD+2027 Cinema attendance ticket(if they do not already hold a WORD+2027 ticket) & travel also reimbursed for winner.
- AXOL Bioscience. Supporting research & drug discovery with iPSC technology.
- Qkine: High-purity, animal-free growth factors, cytokines, and other complex proteins for stem cell and organoid culture.
- Beata Science Art: For the love of science and art to create scientific illustrations and fashion.
Did you miss?
Webinar: From bench to batch: Building reproducible cell and gene therapy workflows with GMP-ready reagents
Join Qkine and BioLife for our live webinar: From bench to batch: Building reproducible cell and gene therapy workflows with GMP-ready reagents.
The webinar will take you through the importance of cytokine quality control in ensuring reproducible and regulatory-ready cell therapy workflows along with the benefits of closed system technologies for decreasing risk and cost.
Qkine secures £1.5 million investment to accelerate stem cell innovation
CPI Enterprises and EverQuest Capital Partners have co-invested alongside Parkwalk and EMV Capital plc in a £1.6 million funding round for Qkine, underscoring their shared commitment to backing high-potential UK life sciences businesses developing innovative technologies with global commercial impact.
The additional investment will support the Qkine's continued growth as we expand production of high-purity, animal-origin-free growth factors, cytokines and complex proteins that are helping improve the reproducibility, scalability and performance of stem cell research and advanced cell therapies.
Product highlight
Recombinant human vitronectin protein (Qk120)
Vitronectin protein is widely used in stem cell culture. It provides a defined environment that supports the maintenance of pluripotency and is suitable for feeder-free culture, expansion, differentiation, and reprogramming of stem cells.
Qkine vitronectin is a high-purity animal origin-free recombinant protein with a molecular weight of 47.8 kDa. It is carrier-free and protein tag-free, ensuring exceptional lot-to-lot consistency and compatibility with translational studies and iPSC-based model production for screening. Qkine recombinant vitronectin protein is ultra high-purity with exceptionally low residual endotoxins making it suitable for the reproducible culture of stem cells, primary cells, organoids, and use in sensitive neural differentiations.
Qk120 has been extensively validated for iPSC culture and differentiation in-house and by collaborators.
Imaging of iPSC colonies grown on Qkine vitronectin coated plates in E8-like media retained their highly preserved morphological appearance. (A) after initial seeding and 3 days in culture; (B) After 1 passage and 7 days in culture; (C) After 3 passages and 14 days in culture (scale bar = 150 µm). 6-well plates were coated with 5 µg/ml Qk120 vitronectin protein lot #204660.
Protein family focus - Transforming growth factor beta (TGF-β) superfamily
The TGF-β superfamily of proteins play diverse roles in embryonic development, morphogenesis, adult stem cell differentiation, wound healing, immune regulation, cancer and inflammation.
Encompassing a range of proteins including TGF-β, growth differentiation factors (GDFs) and bone morphogenetic proteins (BMPs), glial-derived neurotrophic factor (GDNF), inhibins, activins, nodal, lefty, and Mülllerian inhibiting substance (MIS).
Starting with activin A (Qk001), Qkine have become expert in the animal-free expression of TGF-β family members, creating TGF-β1 PLUS™ (Qk010), the first entirely animal origin-free recombinant human TGF-β1 protein for highly reproducible results and compatible with chemically-defined stem cell media.
Activins
Activins are secreted proteins which function as dimers of two inhibinβ chains linked by a disulfide bond. These proteins include ligands, receptors and signaling molecules with essential roles in growth, differentiation and proliferation in a wide range of cell types.
- Activin A protein (Qk001)
- Activin A PLUS™ protein (Qk005)
- Activin AB protein (Qk127)
- Activin B protein (Qk024)
- Activin C protein (Qk026)
- Activin E PLUS™ protein (Qk067)
- Activin E PLUS™ (Avi-tag) protein (Qk082)
Coming soon
Differentiated RPE using Qkine activin A (Qk001)
(A) Light microscope image of a retinal pigmented epithelium (RPE) monolayer differentiated from hiPSC using Qkine human activin A (Qk001) (B) Stained with DAPI (blue) and RPE markers ZO1 (green) and BEST1 (red).
Images provided by Srishti Silvano and Cerys Manning, University of Manchester
BMPs and GDFs
BMPs and GDFs form a family of cystine-knot cytokines which display morphogenetic activities in the development of a wide range of tissues. Existing as homodimers or heterodimers, they have tissue specific functions including the development of bone, kidney, and cardiac tissues.
- BMP-2 protein (Qk007)
- BMP-4 protein (Qk038)
- GDF-5 protein (Qk070)
- GDF-11 (BMP-11) protein (Qk126)
- GDF-15 protein (Qk017)
Coming soon
- GDF-8 (myostatin) protein (Qk124)
Hepatocellular differentiation with BMP-4 (Qk038) and other Qkine animal-free growth factors

Immunocytochemistry of hepatocellular markers in differentiated iPSCs. Albumin [green, A], Hoechst 33258 [blue, B], combined albumin and Hoechst [C], Alpha-1-fetoprotein [green, D], Hoechst 33258 [blue, E], combined alpha-1-fetoprotein and Hoechst [F], and alpha 1 antitrypsin [green, G], Hoechst 33258 [blue, H], alpha 1 antitrypsin and Hoechst [I]. Images were acquired using the EVOS M5000 system (scale bar = 150 µm).
TGF-β
TGF-β1, 2 and 3 signal via receptor complexes consisting of Type I and Type II serine/threonine kinase receptors, activating intracellular SMAD transcription factors. The TGF-β family have a high degree of overlap/redundancy and regulate a variety of cellular functions, including cell survival, proliferation, and differentiation.
TGF-β1 PLUS™ (Qk010) chondrogenic differentiation

Image of cartilage spheroids created using Qkine TGF-β1 PLUS™ (Qk010) by Oliver Gardner/Valeriia Davydenko at Stem Cells and Regenerative Medicine, UCL.
Recent publications
Generative inverse design steers human hematopoietic cell fate in vitro
Paulas-Condori L, Palma A, Consoli L et al. bioRxiv, October 2026
Researchers introduce LabCompass, an inverse-modeling framework that optimizes experimental designs toward candidates expected to produce specified target cell states, using a flow-matching generative model guided by cellular phenotypes predicted by a forward surrogate. They applied LabCompass to primary human CD34+ in vitro cultures, where continuous cytokine and small-molecule parameters govern hematopoietic cell fate, establishing lineage-inducing designs, improved predictions with new data, and enriched target populations across lineages.
Used Qkine human Flt3L (Qk087), GM-CSF (Qk076), SCF (Qk078) and IL-3 (Qk090)
Evaluation of Bone Regeneration by Sustained Release of Bone Morphogenetic Protein from Porous Polyetheretherketone
Genetic control couples TGFβ-independent pluripotent stem cell renewal to deterministic forward programming across germ layers
All our growth factors are manufactured within a stringent quality framework, ensuring high-quality proteins that maintain robust, reproducible, and physiologically relevant stem cell and organoid cultures that adhere to our Nine-point Quality Commitment.
Upcoming Events
- Human Specific Research Community Midlands – Launch Event | 24 November 2026 | Nottingham, UK
- Mercia Stem Cell Alliance 14th Annual Meeting | 1 December 2026 | Leeds, UK
- ISSCR – Disease Modeling and Drug Discovery | 16-18 December 2026 | San Diego, CA, United States
- Organoids are us 2027 | 19-21 January 2027 | Utrecht, The Netherlands
We'd always love to meet you at any event, contact [email protected] to make an appointment.
What’s next?
Qkine are committed to producing the most high quality and bioactive growth factors and cytokines, coming soon to our extensive portfolio:
- Recombinant human activin E PLUS™ Avi-tag (biotinylated) protein (Qk136)
- Recombinant human GDF-8 (myostatin) protein (Qk124)
- Recombinant human BMP-7 protein (Qk028)
- Recombinant human activin AC protein (Qk128)
If you wish to be notified when proteins are released, contact us [email protected]